PeerVoice Immunology & Infectious Disease Audio

PeerVoice
PeerVoice Immunology & Infectious Disease Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

  1. 1月9日

    Mariana Castells, MD, PhD - Rare But Highly Significant: Best Practices in Recognizing and Diagnosing Systemic Mastocytosis

    Visit https://www.peervoice.com/JJU860 to view the entire programme with slides. After completing “Mariana Castells, MD, PhD - Rare But Highly Significant: Best Practices in Recognizing and Diagnosing Systemic Mastocytosis”, participants will be able to: Recognize the prevalence, symptoms, and outcomes associated with systemic mastocytosis (SM); Identify patients who should be referred for diagnostic tests to investigate suspected SM; and Identify diagnostic tests used to investigate and identify cases of SM.

    20 分鐘

  2. 2024/12/12

    Pushpa Narayanaswami, MD, FAAN - Cutting Through the Congress Cacophony on Generalised Myasthenia Gravis: Expert Honing of the Latest Data

    Visit https://www.peervoice.com/HTH860 to view the entire programme with slides. After completing “Pushpa Narayanaswami, MD, FAAN - Cutting Through the Congress Cacophony on Generalised Myasthenia Gravis: Expert Honing of the Latest Data”, participants will be able to: Analyse the evidence and characteristics of next-generation and new formulations of therapies for generalised myasthenia gravis (gMG) and how they differentiate within class; Translate emerging clinical data for approved targeted therapies in the context of current clinical practice for the management of patients with gMG; and Evaluate data on emerging novel therapies for gMG.

    59 分鐘

  3. 2024/11/21

    Onyema Ogbuagu, MD, FACP, FIDSA - Multidrug-Resistant HIV: Evaluating HIV Treatment Strategies as Options Narrow

    Visit https://www.peervoice.com/BQX860 to view the entire programme with slides. After completing “Onyema Ogbuagu, MD, FACP, FIDSA - Multidrug-Resistant HIV: Evaluating HIV Treatment Strategies as Options Narrow”, participants will be able to: Identify patient and disease characteristics that can impact decisions on next treatment steps for individuals living with multidrug-resistant HIV (MDR HIV); and Propose individualised evidence-based treatment strategies to optimise outcomes of individuals living with MDR HIV.

    26 分鐘

  4. 2024/11/15

    Stephen Jolles, MRCP, FRCPath, PhD - The Many Faces of Primary Immunodeficiencies: Exploring the Plethora of Possibilities Impacting Patient-Integrated Care

    Visit https://www.peervoice.com/JGN860 to view the entire programme with slides. After completing “Stephen Jolles, MRCP, FRCPath, PhD - The Many Faces of Primary Immunodeficiencies: Exploring the Plethora of Possibilities Impacting Patient-Integrated Care”, participants will be able to: Recognise the need for an early and accurate diagnosis of primary immunodeficiency diseases (PID); Differentiate between the clinical presentation of infectious and non-infectious manifestations of PID; Use patient factors, clinical features and laboratory testing to facilitate an effective approach to a timely and accurate diagnosis of PID; and Propose an individualised approach to patient-integrated care of PID that optimises therapeutic and management needs of patients and clinicians.

    1 小時 15 分鐘

  5. 2024/09/30

    Frank Siebenhaar, PD / Vito Sabato, MD, PhD - Optimising Outcomes in Indolent Systemic Mastocytosis: A Comprehensive Review of Best Practices Across the Patient Journey

    Visit https://www.peervoice.com/NXY860 to view the entire programme with slides. After completing “Frank Siebenhaar, PD / Vito Sabato, MD, PhD - Optimising Outcomes in Indolent Systemic Mastocytosis: A Comprehensive Review of Best Practices Across the Patient Journey”, participants will be able to: Differentiate the symptoms, causes and outcomes associated with childhood-onset and adult-onset presentations of mastocytosis; Utilise recommended clinical tools for the evaluation of symptoms and quality of life (QoL) in patients with indolent systemic mastocytosis (ISM); and Implement evidence-based best practices in the diagnosis, monitoring and management of ISM.

    29 分鐘

  6. 2024/08/27

    Sharon Walmsley, MD - If the Drugs Are Working, Why Switch HIV Treatment in People Who Are Virologically Suppressed?

    Visit https://www.peervoice.com/VZX860 to view the entire programme with slides. After completing “Sharon Walmsley, MD - If the Drugs Are Working, Why Switch HIV Treatment in People Who Are Virologically Suppressed?”, participants will be able to: Explain the rationale for switching antiretroviral therapy (ART) regimens in people with virologically suppressed HIV; Assess the clinical and patient-reported outcomes (PRO) data for HIV switch regimens for people with virologically suppressed HIV; and Based on clinical trial populations, evaluate eligibility criteria of people with virologically suppressed HIV for an ART switch.

    19 分鐘

  7. 2024/08/23

    Jane Anderson, FRCP, PhD - Health-Related Quality of Life: What Works Best for People Living With HIV?

    Visit https://www.peervoice.com/FDX860 to view the entire programme with slides. After completing “Jane Anderson, FRCP, PhD - Health-Related Quality of Life: What Works Best for People Living With HIV?”, participants will be able to: Summarise the rationale for integrating patient-reported outcomes (PRO) instruments into routine clinical practice when caring for people living with HIV; Explain how PRO measures (PROM) can be effectively integrated into routine clinical practice; Identify how PRO can inform HIV treatment plans that optimise outcomes; and Propose practical approaches to overcoming communication challenges when exploring quality of life (QoL) alongside clinical outcomes with people living with HIV.

    46 分鐘

  8. 2024/07/10

    Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA

    Visit https://www.peervoice.com/AFQ860 to view the entire programme with slides. After completing “Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA”, participants will be able to: Describe the rationale, design, and key areas of focus of the Rheumacensus programmes in psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA); Identify the overarching calls to action needed to implement a paradigm shift designed to elevate health outcomes in patients with PsA and axSpA, as defined by the Rheumacensus Consensus Council; and Propose practical steps to elevate the standard of care for patients with PsA and axSpA based upon results of the Rheumacensus Initiatives.

    16 分鐘
顯示全部 (48)

簡介

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

資訊

「PeerVoice」的更多內容

若要收聽兒少不宜的單集，請登入帳號。

隨時掌握此節目最新消息

登入或註冊後，即可追蹤節目、儲存單集和掌握最新資訊。
選取國家或地區

非洲、中東和印度

亞太地區

歐洲

拉丁美洲與加勒比海地區

美國與加拿大